Mangeng M Cheng

Title: Innovations in Cancer Treatment by Mangeng M Cheng

Introduction

Mangeng M Cheng is a notable inventor based in Stoughton, PA, who has made significant contributions to the field of cancer treatment. With a focus on innovative methods, he has developed a patent that addresses the urgent need for effective cancer therapies.

Latest Patents

Cheng holds a patent for "Methods of treating various cancers using an AXL/cMET inhibitor in combination with other agents." This application describes the use of a specific compound, either alone or in combination with other therapeutically active agents, for the treatment of various cancers, including solid or hematological cancers where AXL or c-Met is over-expressed. This innovative approach has the potential to enhance treatment efficacy and improve patient outcomes.

Career Highlights

Cheng is currently associated with Ignyta, Inc., a company dedicated to advancing precision medicine for cancer patients. His work at Ignyta has positioned him at the forefront of cancer research and development, allowing him to contribute to groundbreaking therapies.

Collaborations

Cheng collaborates with esteemed colleagues, including Thelma S Angeles and Mark A Ator, who share his commitment to advancing cancer treatment. Their combined expertise fosters a collaborative environment that drives innovation in the field.

Conclusion

Mangeng M Cheng's contributions to cancer treatment through his innovative patent highlight the importance of research and collaboration in developing effective therapies. His work continues to inspire advancements in the fight against cancer.